Back to Search Start Over

Comprehensive analysis ofHFEgene in hereditary hemochromatosis and in diseases associated with acquired iron overload

Authors :
Fernanda Fernandes Souza
Juliana Doblas Massaro
Ana de Lourdes Candolo Martinelli
Andreza Correa Teixeira
Aguinaldo Luiz Simões
Wagner Narciso de Campos
Cláudia Emília Vieira Wiezel
Celso T. Mendes-Junior
Eduardo Luiz Rachid Cançado
Eduardo Antônio Donadi
Source :
World Journal of Hepatology
Publication Year :
2019
Publisher :
Baishideng Publishing Group Inc., 2019.

Abstract

BACKGROUND Patients with hepatitis C virus (HCV) and hepatocellular carcinoma (HCC) may or not develop iron overload (IO), which is associated with worst prognosis, because can cause serious damage to organs. HFE gene controls the iron uptake from gut, particularly in patients with hereditary hemochromatosis (HH). AIM To identify associations between HFE coding region in patients exhibiting hereditary hemochromatosis and in diseases associated with acquired IO. METHODS We sequenced exons 2 to 5 and boundary introns of HFE gene, evaluating all polymorphic sites in patients presenting hereditary (hemochromatosis) or acquired iron overload HCV and HCC) and in healthy controls, using Sanger sequencing. We also determined the ensemble of extended haplotype in healthy control individuals, including several major histocompatibility complex loci, using sequence specific probes. Haplotype reconstruction was performed using the Arlequin and Phase softwares, and linkage disequilibrium (LD) between histocompatibility loci and HFE gene was performed using the Haploview software. RESULTS The HFE*003 allele was overrepresented (f = 71%) and HFE*001 allele was underrepresented (f = 14%) in HH patients compared to all groups. A strong linkage disequilibrium was observed among the H63D-G, IVS2(+4)-C and C282Y-G gene variants, particularly in HH; however, the mutation IVS2(+4)T>C was not directly associated with HH susceptibility. The HFE*001/HFE*002 genotype conferred susceptibility to HCC in HCV patients exhibiting IO (P = 0.02, OR = 14.14). Although HFE is telomeric to other histocompatibility genes, the H63D-G/IVS2(+4)-C (P ≤ 0.00001/P ≤ 0.0057) combination was in LD with HLA-B*44 allele group in healthy controls. No LD was observed between HFE alleles and other major histocompatibility loci. CONCLUSION A differential HFE association was observed for HH and for diseases associated with acquired IO (HCV, HCC). Since HFE is very distant from other histocompatibility loci, only weak associations were observed with these alleles.

Details

ISSN :
19485182
Volume :
11
Database :
OpenAIRE
Journal :
World Journal of Hepatology
Accession number :
edsair.doi.dedup.....8ae8aeb25efdf32f2b221e691a2b8a97
Full Text :
https://doi.org/10.4254/wjh.v11.i2.186